Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United
States. Ann Intern Med.1999;130:545-553.
Grady D, Rubin SM, Petitti DB.
et al. Hormone therapy to prevent disease and prolong life in postmenopausal
women. Ann Intern Med.1992;117:1016-1037.
Manson JE, Martin KA. Postmenopausal hormone-replacement therapy. N Engl J Med.2001;345:34-40.
The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational
study. Control Clin Trials.1998;19:61-109.
Col NF, Eckman MH, Karas RH.
et al. Patient-specific decisions about hormone replacement therapy in postmenopausal
Hillner BE, Hollenberg JP, Pauker SG. Postmenopausal estrogens in prevention of osteoporosis: benefit virtually
without risk if cardiovascular effects are considered. Am J Med.1986;80:1115-1127.
Sourander L, Rajala T, Raiha I, Makinen J, Erkkola R, Helenius H. Cardiovascular and cancer morbidity and mortality and sudden cardiac
death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet.1998;352:1965-1969.
Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease. Prev Med.1991;20:47-63.
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy. Lancet.1997;350:1047-1059.
Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol.1995;85:304-313.
Grady D, Wenger NK, Herrington D.
et al. Postmenopausal hormone therapy increases risk for venous thromboembolic
disease. Ann Intern Med.2000;132:689-696.
Grodstein F, Stampfer MJ, Colditz GA.
et al. Postmenopausal hormone therapy and mortality. N Engl J Med.1997;336:1769-1775.
Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. JAMA.1996;276:1172-1177.
Hulley S, Grady D, Bush T.
et al. Randomized trial of estrogen plus progestin for secondary prevention
of coronary heart disease in postmenopausal women. JAMA.1998;280:605-613.
Grady D, Applegate W, Bush T, Furberg C, Riggs B, Hulley SB. Heart and Estrogen/progestin Replacement Study (HERS): design, methods,
and baseline characteristics. Control Clin Trials.1998;19:314-335.
Hlatky MA, Boineau RE, Higginbotham MB.
et al. A brief self-administered questionnaire to determine functional capacity
(the Duke Activity Status Index). Am J Cardiol.1989;64:651-654.
Ware JE, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36), I. Med Care.1992;30:473-483.
Stewart AL, Hays RD, Ware JE. The MOS Short-Form general health survey: reliability and validity
in a patient population. Med Care.1988;26:724-735.
Stewart AL, Greenfield S, Hays RD.
et al. Functional status and well-being of patients with chronic conditions:
results from the Medical Outcomes Study. JAMA.1989;262:907-913.
Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive
disorders. Med Care.1988;26:775-789.
Jennrich RI, Schluchter MD. Unbalanced repeated measures models with structured covariance matrices. Biometrics.1986;42:805-820.
Simon JA, Hsia J, Cauley JA.
et al. Postmenopausal hormone therapy and risk of stroke. Circulation.2001;103:638-642.
Hsia J, Simon JA, Lin F.
et al. Peripheral arterial disease in randomized trial of estrogen with progestin
in women with coronary heart disease. Circulation.2000;102:2228-2232.
Cauley JA, Black DM, Barrett-Connor E.
et al. Effects of hormone replacement therapy on clinical fractures and height
loss. Am J Med.2001;110:442-450.
Simon JA, Hunninghake DB, Agarwal SK.
et al. Effect of estrogen plus progestin on risk for biliary tract surgery
in postmenopausal women with coronary artery disease. Ann Intern Med.2001;135:493-501.
Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T. Postmenopausal hormones and incontinence. Obstet Gynecol.2001;97:116-120.
Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal
estradiol therapy. Am J Obstet Gynecol.1993;168:824-830.
Limouzin-Lamothe MA, Mairon N, Joyce CRB, Le Gal M. Quality of life after the menopause. Am J Obstet Gynecol.1994;170:618-624.
Greendale GA, Reboussin BA, Hogan P.
et al. Symptom relief and side effects of postmenopausal hormones. Obstet Gynecol.1998;92:982-988.
Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. JAMA.1995;273:59-65.
Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients
with multivessel disease. N Engl J Med.1996;335:217-225.
Pocock SJ, Henderson RA, Seed P, Treasure T, Hampton JR. Quality of life, employment status, and anginal symptoms after coronary
angioplasty or bypass surgery. Circulation.1996;94:135-142.
Croog SH, Levine S, Testa MA.
et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med.1986;314:1657-1664.
Ware Jr JE. SF-36 Health Survey Manual and Interpretation Guide. Boston, Mass: The Health Institute, New England Medical Center; 1993.